UK markets closed

Rocket Pharmaceuticals, Inc. (9IP1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
17.08-2.49 (-12.72%)
At close: 02:22PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
185,198
186,342
165,570
125,476
105,438
-
Selling general and administrative
79,642
73,317
58,773
41,772
28,865
-
Total operating expenses
264,840
259,659
223,843
166,248
134,303
-
Operating income or loss
-264,840
-259,659
-223,843
-166,248
-134,303
-
Interest expense
1,878
1,875
1,909
5,889
7,547
-
Total other income/expenses net
-
-
-
-
-580
1,175
Income before tax
-249,314
-245,595
-221,863
-169,069
-139,700
-
Income from continuing operations
-249,314
-245,595
-221,863
-169,069
-139,700
-
Net income
-249,314
-245,595
-221,863
-169,069
-139,700
-
Net income available to common shareholders
-249,314
-245,595
-221,863
-169,069
-139,700
-
Basic EPS
-3.19
-
-3.26
-2.67
-2.52
-1.58
Diluted EPS
-3.19
-
-3.26
-2.67
-2.52
-1.58
Basic average shares
79,743
-
68,149
63,235
55,381
49,010
Diluted average shares
79,743
-
68,149
63,235
55,381
49,010